Zobrazeno 1 - 6
of 6
pro vyhledávání: '"MacConaill, Laura"'
Autor:
Kacew AJ; Medical Oncology, Dana-Farber Cancer Institute, USA., Harris EJ; Medical Oncology, Dana-Farber Cancer Institute, USA., Lorch JH; Medical Oncology, Dana-Farber Cancer Institute, USA., Haddad RI; Medical Oncology, Dana-Farber Cancer Institute, USA., Chau NG; Medical Oncology, Dana-Farber Cancer Institute, USA., Rabinowits G; Hematology/Oncology, Miami Cancer Institute, USA., LeBoeuf NR; Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, USA., Schmults CD; Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, USA., Thakuria M; Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, USA., MacConaill LE; Department of Pathology and Center for Cancer Genome Discovery, Dana-Farber/Brigham and Women's Cancer Center, USA., Hanna GJ; Medical Oncology, Dana-Farber Cancer Institute, USA. Electronic address: glenn_hanna@dfci.harvard.edu.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 May; Vol. 113, pp. 1-9. Date of Electronic Publication: 2019 Apr 04.
Autor:
Choy E; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., MacConaill LE; Center for Cancer Genome Discovery and Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America., Cote GM; Division of Hematology Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Le LP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Shen JK; Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Nielsen GP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Garraway LA; Center for Cancer Genome Discovery and Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America., Hornicek FJ; Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America., Duan Z; Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2014 Jul 01; Vol. 9 (7), pp. e101283. Date of Electronic Publication: 2014 Jul 01 (Print Publication: 2014).
Autor:
Kieran MW; Director, Pediatric Medical Neuro-Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Pediatric Hematology/Oncology, Boston, MA 02215, USA. mark_kieran@dfci.harvard.edu, Roberts CW, Chi SN, Ligon KL, Rich BE, Macconaill LE, Garraway LA, Biegel JA
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2012 Dec 15; Vol. 59 (7), pp. 1155-7. Date of Electronic Publication: 2012 Sep 19.
Autor:
Grill J; Brain Tumor Program, Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Institute, Universite Paris Sud, Villejuif, France. grill@igr.fr, Puget S, Andreiuolo F, Philippe C, MacConaill L, Kieran MW
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2012 Apr; Vol. 58 (4), pp. 489-91. Date of Electronic Publication: 2011 Dec 20.
Autor:
MacConaill LE; Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA., Hughes CM, Rozenblatt-Rosen O, Nannepaga S, Meyerson M
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2006 Oct; Vol. 4 (10), pp. 793-801.
Autor:
Kieran, Mark W., Roberts, Charles W.M., Chi, Susan N., Ligon, Keith L., Rich, Benjamin E., MacConaill, Laura E., Garraway, Levi A., Biegel, Jaclyn A.
Rhabdoid tumors (also called atypical teratoid/rhabdoid tumor (AT/RT) in the brain), are highly malignant, poor prognosis lesions arising in the kidneys, soft tissues, and central nervous system. Targeted therapy in this disease would benefit from ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9bd3d486e02f6e0fdcf7edb9b11d51ad
https://europepmc.org/articles/PMC3538080/
https://europepmc.org/articles/PMC3538080/